Versantis is a clinical-stage pharmaceutical company developing a new generation of orphan medicines to revolutionize the care of patients with liver and rare pediatric diseases. We address the unmet medical needs in emergency care. Our mission is to support acute decompensations of cirrhosis and to save infants born with rare genetic disorders.
View Top Employees from VersantisWebsite | http://www.versantis.com |
Revenue | $3 million |
Funding | $20.7 million |
Employees | 6 (6 on RocketReach) |
Founded | 2015 |
Phone | +41 44 500 88 91 |
Technologies |
JavaScript,
HTML,
PHP
+15 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Drug Stores & Pharmacies, Health Care, Hepatology, Retail, Health Diagnostics, Hyperammonemia, Pharmaceutical, Metabolic disease, Therapeutics, Liver diseases |
Web Rank | 8 Million |
Keywords | Versantis |
Competitors | Brickell Biotech, Inc., Follica, Inc., NeurOp, Inc., ONL Therapeutics, Relmada Therapeutics, Inc |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies |
Looking for a particular Versantis employee's phone or email?
The Versantis annual revenue was $3 million in 2024.
Lise-Marie Fueg is the Head CMC of Versantis.
6 people are employed at Versantis.
The NAICS codes for Versantis are [3254, 325, 32, 32541].
The SIC codes for Versantis are [28, 283].